MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer

被引：0
|
作者：
Jinzhi Lai
Hainan Yang
Yanyang Zhu
Mei Ruan
Yayu Huang
Qiuyu Zhang
机构：
[1] Fujian Medical University,Department of Oncology, The Second Affiliated Hospital
[2] Fujian Medical University,Institute of Immunotherapy
[3] The Second Affiliated Hospital,Department of Ultrasound
[4] Fujian Medical University,undefined
来源：
BMC Cancer | / 19卷
关键词：
Small cell lung cancer; MiR-7-5p; Chemo-resistance; Doxorubicin; Poly ADP-ribose polymerase 1; Homologous recombination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The regulation of autophagy by the miR-199a-5p/p62 axis was a potential mechanism of small cell lung cancer cisplatin resistance
    Tiezhi Li
    Helin Zhang
    Zhichao Wang
    Shaolin Gao
    Xu Zhang
    Haiyong Zhu
    Na Wang
    Honglin Li
    Cancer Cell International, 22
  • [42] PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer
    Xu, Xianping
    Liu, Yu
    Gong, Qiang
    Ma, Le
    Wei, Wei
    Zhao, Linqiong
    Luo, Zhibin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 209 - 221
  • [43] DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer
    Cao, Jianzhong
    Song, Yongmei
    Bi, Nan
    Shen, Jie
    Liu, Wenyang
    Fan, Jing
    Sun, Guogui
    Tong, Tong
    He, Jie
    Shi, Yuankai
    Zhang, Xun
    Lu, Ning
    He, Yinghua
    Zhang, Hongyu
    Ma, Kelong
    Luo, Xiaoying
    Lv, Lei
    Deng, Hui
    Cheng, Jing
    Zhu, Jingde
    Wang, Luhua
    Zhan, Qimin
    CANCER RESEARCH, 2013, 73 (11) : 3326 - 3335
  • [44] Propofol suppresses the progression of non-small cell lung cancer via downregulation of the miR-21-5p/MAPK10 axis
    Wu, Xinhua
    Li, Xuebin
    Xu, Guiping
    ONCOLOGY REPORTS, 2020, 44 (02) : 487 - 498
  • [45] Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer
    Li, Qian-Qian
    Xie, You-Ke
    Wu, Yue
    Li, Lin-Lin
    Liu, Ying
    Miao, Xiao-Bo
    Liu, Qiu-Zhen
    Yao, Kai-Tai
    Xiao, Guang-Hui
    ONCOTARGET, 2017, 8 (07) : 12067 - 12080
  • [46] Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A
    Pan, Banzhou
    Chen, Yitian
    Song, Haizhu
    Xu, Yichen
    Wang, Rui
    Chen, Longbang
    ONCOTARGET, 2015, 6 (01) : 317 - 331
  • [47] miR-593-5p inhibit cell proliferation by targeting PLK1 in non small cell lung cancer cells
    Yan, Liang
    Zhang, Yizonheng
    Li, Kai
    Wang, Mengze
    Li, Jiaping
    Qi, Zhilin
    Wu, Juan
    Wang, Zhen
    Ling, Liefeng
    Liu, Haijun
    Wu, Yaohua
    Lu, Xinyu
    Xu, Lei
    Zhu, Yiping
    Zhang, Yao
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (02)
  • [48] Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p/miR-615-3p axis
    Han, Bin
    Liu, Yanyan
    Zhang, Qiongqiong
    Liang, Liqun
    JOURNAL OF PROTEOMICS, 2023, 274
  • [49] MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7
    Li, Xiangpan
    Wu, Xiaofei
    ONCOTARGETS AND THERAPY, 2018, 11 : 8445 - 8454
  • [50] MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2
    Xiao, Haiping
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2019, 24 (01) : 1V
12345